Apex Medical Corp. (4106.TW)
TWD 24.5
(1.24%)
TWD 24.5
(1.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 455.65 Million | 82.14 Million | 19 Million | 279.32 Million | 173.62 Million | 118.99 Million |
| Net Income | 209.85 Million | 200.53 Million | 138.08 Million | 124.84 Million | 128.42 Million | 150.27 Million |
| Depreciation & Amortization | 93.76 Million | 93.31 Million | 93.54 Million | 79.27 Million | 80.84 Million | 61.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 179.61 Million | -197.95 Million | -177.81 Million | 114.57 Million | 7.95 Million | -64.8 Million |
| Other non-cash items | -27.57 Million | -13.74 Million | -34.8 Million | -39.37 Million | -43.6 Million | -28.42 Million |
| Investing Cash Flow | -52.89 Million | -32.9 Million | -15.92 Million | 143.44 Million | 35.51 Million | -517.9 Million |
| Investments in PPE | -32.11 Million | -47.99 Million | -52.29 Million | -47.11 Million | -32.35 Million | -172.56 Million |
| Acquisitions | -3.19 Million | 577 Thousand | -3.01 Million | -98.59 Million | -345 Thousand | 1.6 Million |
| Investment purchases | -20.76 Million | -577 Thousand | -2.44 Million | -120 Million | -114 Million | -569.86 Million |
| Sales/Maturities of investments | -1.68 Million | 15.42 Million | 35.19 Million | 330.57 Million | 246.94 Million | 224.52 Million |
| Other Investing Activities | 4.86 Million | -334 Thousand | 6.63 Million | 78.57 Million | -64.73 Million | -1.61 Million |
| Financing Cash Flow | -200.38 Million | -145.83 Million | 81.87 Million | -279.73 Million | -218.77 Million | 442.76 Million |
| Debt repayment | -761.36 Million | -1.33 Billion | -843.51 Million | -1.44 Billion | -985.35 Million | -752.36 Million |
| Dividends payments | -85.77 Million | -55.5 Million | -55.5 Million | -45.41 Million | -65.59 Million | -66.7 Million |
| Common Stock Repurchased | - | - | - | - | - | 387.32 Million |
| Common Stock Issuance | - | - | - | - | - | 874.42 Million |
| Other Financing Activities | 646.76 Million | 1.24 Billion | 980.89 Million | 1.21 Billion | 832.17 Million | 91 Thousand |
| Accounts receivables | 19.9 Million | -143.4 Million | -66.84 Million | 38.35 Million | 71.55 Million | -60.19 Million |
| Accounts payables | 4.44 Million | -31.13 Million | 85.04 Million | -10.12 Million | -70.58 Million | 26.9 Million |
| Inventory | 132.21 Million | 2.38 Million | -180.58 Million | 57.35 Million | 14.5 Million | -13.62 Million |
| Other working capital | 23.04 Million | -25.81 Million | -15.42 Million | 29 Million | -7.5 Million | -51.18 Million |
| Cash at beginning of period | 445.28 Million | 493.22 Million | 470.15 Million | 419.45 Million | 447.21 Million | 409.51 Million |
| Cash at end of period | 648.37 Million | 445.28 Million | 493.22 Million | 470.15 Million | 419.45 Million | 447.21 Million |
| Capital Expenditure | -32.11 Million | -47.99 Million | -52.29 Million | -47.11 Million | -32.35 Million | -172.56 Million |
| Effect of forex changes on cash | 717 Thousand | 48.64 Million | -61.88 Million | -92.32 Million | -18.11 Million | -6.14 Million |
| Net cash flow / Change in cash | 203.09 Million | -47.94 Million | 23.07 Million | 50.7 Million | -27.75 Million | 37.69 Million |
| Free Cash Flow | 423.54 Million | 34.15 Million | -33.28 Million | 232.2 Million | 141.27 Million | -53.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.24 Million | 52.05 Million | 32.99 Million | 209.85 Million | 37.08 Million | 75.03 Million |
| Depreciation & Amortization | 23.87 Million | 22.79 Million | 23.98 Million | 93.76 Million | 24.13 Million | 22.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 71.95 Million | -171.13 Million | 92.96 Million | 179.61 Million | 128.3 Million | -43.24 Million |
| Other non-cash items | -7.83 Million | 2.88 Million | 6.55 Million | -27.57 Million | -15.2 Million | -13.73 Million |
| Investing Cash Flow | -3.99 Million | -2.86 Million | -26.23 Million | -52.89 Million | 8.96 Million | -20.87 Million |
| Investments in PPE | -11.69 Million | -6.25 Million | -6.87 Million | -32.11 Million | -6.84 Million | -7.66 Million |
| Acquisitions | 1.11 Million | 603 Thousand | 10 Thousand | -3.19 Million | 557 Thousand | -334 Thousand |
| Investment purchases | - | - | -5.76 Million | -20.76 Million | 2.87 Million | -12.66 Million |
| Sales/Maturities of investments | 6.78 Million | 2.96 Million | -15.72 Million | -1.68 Million | -557 Thousand | 334 Thousand |
| Other Investing Activities | -199 Thousand | -178 Thousand | 2.12 Million | 4.86 Million | 12.93 Million | -549 Thousand |
| Financing Cash Flow | -82.08 Million | 11.55 Million | -21.56 Million | -200.38 Million | -93.02 Million | -20.04 Million |
| Debt repayment | -76.97 Million | -15.88 Million | -216.72 Million | -761.36 Million | -112.04 Million | -183.71 Million |
| Dividends payments | - | - | - | -85.77 Million | -85.77 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.11 Million | 17.24 Million | 195.16 Million | 646.76 Million | 104.79 Million | 163.67 Million |
| Accounts receivables | 115.52 Million | -73.34 Million | 27.81 Million | 19.9 Million | 59.85 Million | -100.63 Million |
| Accounts payables | -54.45 Million | 16.09 Million | 22.01 Million | 4.44 Million | 33.51 Million | -92.94 Million |
| Inventory | -11.28 Million | -13.07 Million | 16.21 Million | 132.21 Million | 7.72 Million | 101.93 Million |
| Other working capital | 22.17 Million | -100.8 Million | 26.92 Million | 23.04 Million | 27.19 Million | 48.4 Million |
| Cash at beginning of period | 578.03 Million | 648.37 Million | 551.81 Million | 445.28 Million | 462.72 Million | 456.31 Million |
| Cash at end of period | 608.67 Million | 578.03 Million | 648.37 Million | 648.37 Million | 551.81 Million | 462.72 Million |
| Capital Expenditure | -11.69 Million | -6.25 Million | -6.87 Million | -32.11 Million | -6.84 Million | -7.66 Million |
| Effect of forex changes on cash | 5.44 Million | 19.59 Million | -12.13 Million | 717 Thousand | -1.16 Million | 6.61 Million |
| Net cash flow / Change in cash | 30.63 Million | -70.34 Million | 96.56 Million | 203.09 Million | 89.09 Million | 6.41 Million |
| Free Cash Flow | 99.57 Million | -104.88 Million | 149.62 Million | 423.54 Million | 167.46 Million | 33.05 Million |
4760
ACGBF
000825
6875
3131
2062